This finding strongly suggested that the Dd-mrp4 mRNA and/or its product (Dd-MRP4 protein) might act as a new promising target for specifically disrupting cell viability pathways in human tumor cells and consequently for cancer therapy. Here, ABCC4 is linked to cancer.